Initial State Findings Point to Clinical Similarities in Illnesses Among People Who Use E-cigarettes
No single product linked to all cases of lung disease
Initial findings from the investigation into serious lung illnesses associated with e-cigarette products point to clinical similarities among those affected. Patients report similar exposures, symptoms and clinical findings and these align with the CDC health advisory released last week. While many of the patients, but not all, reported recent use of THC-containing products, some reported using both THC- and nicotine-containing products. A smaller group reported using nicotine only.
No evidence of infectious diseases has been identified in these patients, therefore lung illnesses are likely associated with a chemical exposure. However, it is too early to pinpoint a single product or substance common to all cases, according to report.
“We are committed to finding out what is making people sick,” said expert. “All available information is being carefully analyzed, and these initial findings are helping us narrow the focus of our investigation and get us closer to the answers needed to save lives.”
CDC, FDA, and state partners are combining information about e-cigarette exposures, results from FDA testing of product samples, and clinical testing results to identify a cause or causes of these illnesses.
“The FDA appreciates the continued collaboration between our federal and state public health partners to get to the bottom of these distressing incidents and gather more information about any products or substances used. We are leaving no stone unturned in following any potential leads and we’re committed to taking appropriate actions as the facts emerge,” said expert. “Our laboratory is working closely with our federal and state partners to identify the products or substances that may be causing the illnesses and have received more than 120 samples from the states so far. The FDA is analyzing these for a broad range of chemicals but no one substance, including Vitamin E acetate, has been identified in all of the samples tested. Importantly, identifying any compounds present in the samples will be one piece of the puzzle but won’t necessarily answer questions about causality, which makes our ongoing work critical.”
CDC launched a multistate investigation into the lung illnesses on August 1, 2019, and has worked closely since then with FDA, states and other public health partners, and clinicians to determine the cause. As of today, more than 25 states have reported possible cases of lung illnesses associated with use of e-cigarette products (e.g., devices, liquids, refill pods, and cartridges).
At least two deaths have been reported to CDC. Additional cases of lung illness are being investigated to determine whether they are linked to e-cigarette use and have similar clinical features. This includes looking back for older cases based on CDC’s case definition. States are in the process of classifying possible cases, and this information will be reported next week.
Source: U.S. Centers for Disease Control and Prevention
- 230 reads
Human Rights
Fostering a More Humane World: The 28th Eurasian Economic Summi

Conscience, Hope, and Action: Keys to Global Peace and Sustainability

Human Rights Event: Discussing the Future of Governance Experts from 56 Countries Participated in the ICCJW

Ringing FOWPAL’s Peace Bell for the World:Nobel Peace Prize Laureates’ Visions and Actions

Protecting the World’s Cultural Diversity for a Sustainable Future

Global Celebration of International Day of Conscience: Dr. Hong, Tao-Tze Unites Participants from 63 Nations

Puppet Show I International Friendship Day 2020